Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Cash & Equivalents
$517.00M
Quarterly · Period ending: · USD

BIO Cash & Equivalents
Latest reported$517.00Mperiod ending
Latest reported$517.00Mperiod ending
BIO Quarterly Cash & Equivalents ($6.00M → $517.00M)
Quarterly Cash & Equivalents
High-resolution chart · PNG
BIO cash & equivalents history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 26,066,000 | |
| 9,994,000 | |
| 13,954,000 | |
| 8,586,000 | |
| 13,071,000 | |
| 15,321,000 | |
| 17,100,000 | |
| 11,800,000 | |
| 11,600,000 | |
| 8,000,000 | |
| 10,100,000 | |
| 8,300,000 | |
| 13,500,000 | |
| 12,600,000 | |
| 10,800,000 | |
| 4,700,000 | |
| 5,500,000 | |
| 10,700,000 | |
| 9,400,000 | |
| 25,300,000 | |
| 26,400,000 | |
| 18,000,000 | |
| 14,800,000 | |
| 7,600,000 | |
| 5,000,000 | |
| 5,900,000 | |
| 3,800,000 | |
| 3,900,000 | |
| 4,800,000 | |
| 5,700,000 | |
| 3,100,000 | |
| 2,600,000 | |
| 3,900,000 | |
| 3,800,000 | |
| 2,700,000 | |
| 2,400,000 | |
| 3,700,000 | |
| 5,100,000 | |
| 4,800,000 | |
| 2,800,000 | |
| 2,500,000 | |
| 3,300,000 | |
| 2,000,000 | |
| 3,500,000 | |
| 4,900,000 | |
| 4,900,000 | |
| 2,900,000 | |
| 3,700,000 | |
| 2,300,000 | |
| 4,000,000 | |
| 1,900,000 | |
| 2,100,000 | |
| 6,000,000 |